> top > docs > PubMed:10992168 > annotations

PubMed:10992168 JSONTXT

Annnotations TAB JSON ListView MergeView

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 126-138 HP_0100602 denotes preeclampsia
T2 465-477 HP_0100602 denotes preeclampsia
T3 1131-1143 HP_0100602 denotes preeclampsia
T4 1212-1224 HP_0100602 denotes preeclampsia

Preeclampsia

Id Subject Object Predicate Lexical cue
PD-Preeclampsia-B_T1 0-12 ORPHA:275555 denotes Preeclampsia
PD-Preeclampsia-B_T2 126-138 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T3 465-477 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T4 1131-1143 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T5 1212-1224 ORPHA:275555 denotes preeclampsia

Preeclampsia-compare

Id Subject Object Predicate Lexical cue
PD-Preeclampsia-B_T1 0-12 ORPHA:275555 denotes Preeclampsia
PD-Preeclampsia-B_T2 126-138 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T3 465-477 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T4 1131-1143 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T5 1212-1224 ORPHA:275555 denotes preeclampsia

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-74 Sentence denotes Preeclampsia prevention: lessons from the low-dose aspirin therapy trials.
TextSentencer_T2 75-156 Sentence denotes The ability of low-dose aspirin therapy to prevent preeclampsia is controversial.
TextSentencer_T3 157-413 Sentence denotes The 19 randomized, placebo-controlled trials of low-dose aspirin therapy reported in the literature were categorized according to the risk factors of the women studied-nulliparity, underlying medical illness, poor obstetric history, and multiple gestation.
TextSentencer_T4 414-622 Sentence denotes Low-dose aspirin therapy reduced the incidences of preeclampsia among women with poor obstetric histories and among high-risk nulliparous women but was ineffective among women with underlying medical illness.
TextSentencer_T5 623-745 Sentence denotes It was marginally effective among low-risk nulliparous women, and benefits for women with multiple gestations are unclear.
TextSentencer_T6 746-944 Sentence denotes More research is needed to better identify high-risk nulliparous women who might benefit from the use of low-dose aspirin therapy and to define potential benefits for women with multiple gestations.
TextSentencer_T7 945-1144 Sentence denotes The differential effects of low-dose aspirin therapy in the various risk groups are probably a result of varying roles in the groups of abnormal arachidonic acid metabolism in mediating preeclampsia.
TextSentencer_T8 1145-1236 Sentence denotes It is premature to abandon the use of low-dose aspirin therapy for preeclampsia prevention.
T1 0-74 Sentence denotes Preeclampsia prevention: lessons from the low-dose aspirin therapy trials.
T2 75-156 Sentence denotes The ability of low-dose aspirin therapy to prevent preeclampsia is controversial.
T3 157-413 Sentence denotes The 19 randomized, placebo-controlled trials of low-dose aspirin therapy reported in the literature were categorized according to the risk factors of the women studied-nulliparity, underlying medical illness, poor obstetric history, and multiple gestation.
T4 414-622 Sentence denotes Low-dose aspirin therapy reduced the incidences of preeclampsia among women with poor obstetric histories and among high-risk nulliparous women but was ineffective among women with underlying medical illness.
T5 623-745 Sentence denotes It was marginally effective among low-risk nulliparous women, and benefits for women with multiple gestations are unclear.
T6 746-944 Sentence denotes More research is needed to better identify high-risk nulliparous women who might benefit from the use of low-dose aspirin therapy and to define potential benefits for women with multiple gestations.
T7 945-1144 Sentence denotes The differential effects of low-dose aspirin therapy in the various risk groups are probably a result of varying roles in the groups of abnormal arachidonic acid metabolism in mediating preeclampsia.
T8 1145-1236 Sentence denotes It is premature to abandon the use of low-dose aspirin therapy for preeclampsia prevention.